ContextVision AB - Mandatory notification of trade



Stockholm, March 22nd, 2016


Anita Tollstadius, CEO and primary insider in ContextVision AB, has between March 21st and March 22nd 2016 purchased 2 000 shares in ContextVision AB at an average price of NOK 32,45 per share.
Following this transaction, Anita Tollstadius owns 7 000 shares in ContextVision AB. Anita Tollstadius also owns 10 000 shares through her 100% owned company Tollstadius & Co AB.
 
For inquires please contact CEO Anita Tollstadius; anita.tollstadius@contextvision.se

This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act.

 

About ContextVision

ContextVision's cutting-edge technology helps doctors more accurately interpret medical images, a crucial foundation for better diagnosis and treatment. An industry pioneer for more than 30 years, the company's state-of-the-art medical image analysis and enhancement software for 2D/3D/4D Ultrasound, MRI, X-Ray and Mammography is used by leading equipment manufacturers worldwide. ContextVision continues to invest heavily in R&D in order to expand its technology platform. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.


Pièces jointes

ContextVision - Mandatory notification of trade
GlobeNewswire